Tunisia to spend $100m to acquire COVID-19 vaccines
The North African country according to Mahdi will acquire the vaccine from several producers including Pfizer with whom it has already struck a delivery deal.
The World Bank-backed budget will cover purchases from laboratories whose vaccines are more than 90 per cent efficient and meet security norms.
Earlier this month, Mahdi and several health officials indicated at a press conference that Tunisia will acquire covid-19 vaccine in the Q1 of next year and that the vaccination will be free of charge.
Tunisia has so far recorded 114,547 COVID-19 cases and 3,997 fatalities since the report of the first case in February.